David Schubert

David Schubert

Company: Roche

Job title: Principal Scientist


A Novel IgG-IL2 Mutein to Selectively Activate T Regulatory Cells 2:45 pm

• Design and development of an IL-2 mutein showing Treg specificity • Assessment of Treg pharmacology in vitro and in vivo in non-clinical studies • Path towards clinical development of Treg therapies using IL-2 muteinsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.